Bruker Corporation
BRKR
$35.54
$1.745.15%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 7.60M | 17.40M | 13.70M | 40.90M | 7.60M |
Total Depreciation and Amortization | 56.10M | 50.40M | 52.90M | 51.00M | 45.20M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -30.90M | -12.10M | 32.40M | -6.10M | 6.70M |
Change in Net Operating Assets | -160.30M | 9.30M | 91.00M | -47.40M | -58.40M |
Cash from Operations | -127.50M | 65.00M | 190.00M | 38.40M | 1.10M |
Capital Expenditure | -21.30M | -26.00M | -36.70M | -32.60M | -24.60M |
Sale of Property, Plant, and Equipment | -- | -- | 200.00K | 0.00 | -- |
Cash Acquisitions | -68.40M | -1.10M | -22.90M | -200.00K | -1.30B |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -1.40M | 1.00M | -1.20M | -34.80M | 1.70M |
Cash from Investing | -91.10M | -26.10M | -60.60M | -67.60M | -1.32B |
Total Debt Issued | 168.30M | 142.80M | 178.10M | 166.90M | 1.61B |
Total Debt Repaid | -65.80M | -175.60M | -231.70M | -158.30M | -850.40M |
Issuance of Common Stock | 4.90M | 400.00K | 3.20M | -- | 405.20M |
Repurchase of Common Stock | 0.00 | -10.00M | -- | -2.80M | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -7.60M | -7.70M | -7.60M | -7.60M | -7.70M |
Other Financing Activities | -4.30M | -1.10M | -17.00M | -900.00K | -1.40M |
Cash from Financing | 95.50M | -51.20M | -75.00M | -2.70M | 1.16B |
Foreign Exchange rate Adjustments | 31.60M | 13.30M | -19.40M | 10.40M | -2.10M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -91.50M | 1.00M | 35.00M | -21.50M | -170.10M |